Diamond Biopharm (India) Private Limited - Company Profile

It is a business services private limited company based in Hyderabad, Telangana, India, established in 2009.
2009 Hyderabad, Telangana, India Struck Off
Last Updated:
Access Report
About Diamond Biopharm (India) Private Limited

Diamond Biopharm (India) Private Limited, a struck off private limited company, was established on 13 July 2009 in Hyderabad, Telangana, India. Engaging in other services within the business services sector, it holds CIN: U74999TG2009PTC064345. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.

Its leadership includes Maureen Graham (Director), Padmaja Bundla (Director), Venkat Kamalakar Bundla (Director). Its latest AGM occurred on 04 August 2012, with the balance sheet filed on 31 March 2012. It is based at No-4, Banjara Basera, Road No-12, Banjara Hills, Hyderabad, Telangana, 500034.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999TG2009PTC064345

  • Registration Number

    064345

  • Incorporation Date

    13 July 2009

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 16 Year, 8 Months
  • Last Filing with ROC 31 Mar 2012
Company report

Diamond Biopharm (India) Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Diamond Biopharm (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Diamond Biopharm (India) Private Limited?
Current Directors
Name Designation Appointment Date Status
Maureen Graham Director 13 Jul 2009 Current
Padmaja Bundla Director 15 Sep 2009 Current
Venkat Kamalakar Bundla Director 13 Jul 2009 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Diamond Biopharm (India).

Enhance accessibility to Diamond Biopharm (India)'s financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Diamond Biopharm (India) revenue growth over time
Diamond Biopharm (India) profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Diamond Biopharm (India)?

Unlock access to Diamond Biopharm (India)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Diamond Biopharm (India)?

Unlock and access historical data on people associated with Diamond Biopharm (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Diamond Biopharm (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Diamond Biopharm (India)'s trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Diamond Biopharm (India)
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Diamond Biopharm (India) Private Limited last Annual general meeting of members was held on 04 Aug 2012 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Diamond Biopharm (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2012 with Roc Hyderabad. was completed.

  • Director Appointment

    Progress on Padmaja Bundla was appointed as a Director was appointed as a Director on 15 Sep 2009 & has been associated with this company since 16 years 5 months . was documented.

  • Director Appointment

    The activity Maureen Graham was appointed as a Director was appointed as a Director on 13 Jul 2009 & has been associated with this company since 16 years 8 months . was completed.

  • Director Appointment

    Venkat Kamalakar Bundla was appointed as a Director was appointed as a Director on 13 Jul 2009 & has been associated with this company since 16 years 8 months . was recorded as a recent event.

  • Company Incorporation

    Progress on Diamond Biopharm (India) Private Limited was registered on 13 Jul 2009 with Roc Hyderabad & aged 16 years 8 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Diamond Biopharm (India) Private Limited?

The CIN of Diamond Biopharm (India) Private Limited is U74999TG2009PTC064345.

Where is Diamond Biopharm (India) Private Limited headquartered?

Diamond Biopharm (India) Private Limited is headquartered at No-4, Banjara Basera, Road No-12, Banjara Hills, Hyderabad, Telangana, 500034.

When was Diamond Biopharm (India) Private Limited incorporated?

Diamond Biopharm (India) Private Limited was incorporated on 13 July 2009.

Who are the current directors of Diamond Biopharm (India) Private Limited?

The current directors of Diamond Biopharm (India) Private Limited are

What is the primary industry of Diamond Biopharm (India) Private Limited?

The primary industry of Diamond Biopharm (India) Private Limited is Business Services.

Is Diamond Biopharm (India) Private Limited a listed company?

Diamond Biopharm (India) Private Limited is unlisted.

What is the capital structure of Diamond Biopharm (India) Private Limited?

The authorized capital of Diamond Biopharm (India) Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available